Somnogen’s primary strategy is to develop, manufacture, and commercialize ANDAs and NDAs. However, currently in order to offer our customers a varied and broad product portfolio within the sleep/wakefulness therapeutics, we will also be acquiring or licensing additional products that fulfill our niche.

Somnogen’s products are marketed through national wholesalers and distributors, and direct to major warehousing customers. Our target markets include wholesaler multi-source programs, chain drug stores, managed healthcare providers, and institutional (government or private) healthcare facilities.

This store is powered by Ecwid – AJAX shopping cart. If you your browser does not support JavaScript, please proceed to its simple HTML version.


Statements on this web site have not be evaluated by the Food and Drug Administration and are not meant to diagnose, treat or cure any disease or illness. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.

Share This Page

Corporate Social Responsibility

image Somnogen will develop a unique culture thereby giving back is both an individual and society. Such requests will be evaluated on individual basis and resources will be coordinated – including product donations, gifts and grants – to create timely and relevant responses tailored to meet individual, local, national or international challenges.
 group of doctors

Login Form